UNICREDIT BANK/CALL/ABBVIE/150/0.1/18.12.24 Share Price

Warrant

DE000HC3LG51

Real-time BOERSE MUENCHEN 07:01:02 26/06/2024 BST
2.34 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/150/0.1/18.12.24
Current month+52.94%
1 month+67.14%
Date Price Change
26/06/24 2.34 0.00%
25/06/24 2.34 -6.02%
24/06/24 2.49 +5.06%
21/06/24 2.37 -4.82%
20/06/24 2.49 +2.89%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 07:01 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LG5
ISINDE000HC3LG51
Date issued 27/01/2023
Strike 150 $
Maturity 18/12/2024 (176 Days)
Parity 10 : 1
Emission price 1.95
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.46
Lowest since issue 0.83
Delta0.8x
Omega 5.463
Premium2.43x
Gearing6.86x
Moneyness 1.138
Difference Strike -20.75 $
Difference Strike %-13.83%
Spread 0.09
Spread %3.80%
Theoretical value 2.325
Implied Volatility 25.09 %
Total Loss Probability 24.05 %
Intrinsic value 1.939
Present value 0.3863
Break even 174.88 €
Theta-0.02x
Vega0.03x
Rho0.05x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
170.8 USD
Average target price
183.2 USD
Spread / Average Target
+7.31%
Consensus